Search Results

Diagnosis and Endovascular Management of PVI

Pelvic venous insufficiency remains an underdiagnosed but treatable cause of chronic pelvic pain.

By Carl M. Black, MD; Kelly Thorpe, NP; and Ryan Nielsen, MD

Key Elements of a Successful Stroke Team

Organization of an effective stroke team will require strong administrative support and broad multispecialty input.

By Carl M. Black, MD; Jeanie Hammer, BS; and Joseph Watkins, MD

Endovascular Perforator Ablation

Treatment of incompetent perforator reflux can play an important role in the management of chronic venous insufficiency and stasis ulceration.

By Carl M. Black, MD; Robert P. Smilanich, MD; And Eugene R. Worth, MD

Continued Progress in Venous Disease Therapy

By Barry T. Katzen, MD, Chief Medical Editor

Stroke Management

By John R. Laird, Jr, MD, Chief Medical Editor

Venous Issues

By Barry T. Katzen, MD

The Most Impactful Deep Venous Trials to Date

A summary of pivotal and upcoming trials assessing the safety and efficacy of treatment of deep venous disease.

By Misaki Kiguchi, MD, MBA, FACS, and Kyle Reynolds, MD

Diagnosing Deep Venous Disease Through Optimized Imaging: Magnetic Resonance Venography

Imaging central venous disease using magnetic resonance venography.

By Justinas Silickas, MBBS, MRCS; Stephen A. Black, MD, FRCS(Ed), FEBVS; Adam M. Gwozdz, MRCS; Alberto Smith, PhD; and Prakash Saha, PhD, FRCS

Disparities in Access to Care

Social determinants of health related to interventional radiology overall, access to liver-directed therapies and transplantation, and the role of artificial intelligence.

With Laura Findeiss, MD, FSIR, FAHA; Resmi Charalel, MD, MPH; Sarah B. White, MD, MS, FSIR; Veronica M. Loy, DO; and Julius Chapiro, MD, PhD

CHAMPIONS: Providing Access to Vascular Care for the Underserved

Highlights and opportunities from CHAMPIONS, a program aimed at addressing disparities in vascular care in vascular deserts.

By Maria Denalene Tiu, BS, MS; Guistinna Tun, BS; Clara Gomez-Sanchez, MD; and Leigh Ann O’Banion, MD

AI, Automation, and Aortic Aneurysm Care

AI-assisted algorithms with accurate and automated tools for diameter and volumetric monitoring of the aorta have the potential to improve clinical outcomes and patient follow-up after EVAR.

By Dominique Fabre, MD, PhD; Thomas J. Postiglione, MD; and Stéphan Haulon, MD, PhD

Ensuring Satisfaction and Quality Vascular Care as Hospitals Consolidate

Several years ago, Gary M. Ansel, MD, moved from a high-volume private practice into hospital employment, and more recently, when his hospital system began to expand, he took on the role of overseeing the entire system's vascular division. In this interview, Dr. Ansel describes physician compensation models, job satisfaction, and efforts toward establishing high-quality care, regardless of which door a patient passes through.

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

Ask The Experts: Predicting the Next Breakthrough in Superficial Venous Disease Care

A discussion of therapies, technologies, and research that have the potential to transform the next phase of superficial venous disease treatment.

With Eri Fukaya, MD, PhD; Robert B. McLafferty, MD, MBA; and Stephen A. Black, MD, FRCS(Ed), FEBVS

Optimizing TEVAR

By Javairiah Fatima, MD, FACS, FSVS; Ian M. Loftus, MD, FRCS; and Edward Y. Woo, MD

Advances in Treating Thoracic Aortic Dissection

By Matt M. Thompson, MD, FRCS, and Michael D. Dake, MD

TEVAR: Strategizing Success

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS

AI in IO: Big Data, Outcome Repositories, and Clinical Applications

How the expanding health care applications of artificial intelligence may be incorporated to improve interventional oncology processes and care.

By Brian Letzen, MD, MS, and Raul N. Uppot, MD